RUNX1 GENE MUTATION

This adverse event was reported 16 times

RUNX1 GENE MUTATION is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 IDECABTAGENE VICLEUCEL 1 0.0008
1 MITOXANTRONE HYDROCHLORIDE 4 0.0006
2 MELPHALAN HYDROCHLORIDE 5 0.0002
3 CILTACABTAGENE AUTOLEUCEL 1 0.0002
4 ETOPOSIDE 8 0.0001
5 CISPLATIN 8 0.0001
6 CLADRIBINE 1 0.0001
7 BLEOMYCIN SULFATE 1 0.0001
8 CYTARABINE 5 0.0001
9 NIRAPARIB 1 0.0000
See all drugs enriched for association with RUNX1 GENE MUTATION

RUNX1 GENE MUTATION is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Topoisomerase Inhibitor [EPC] 8 0.0001
1 BCL-2 Inhibitor [EPC] 2 0.0000
2 Platinum-based Drug [EPC] 8 0.0000
3 Nucleoside Metabolic Inhibitor [EPC] 5 0.0000
4 Alkylating Drug [EPC] 4 0.0000
5 CD20-directed Cytolytic Antibody [EPC] 4 0.0000
6 Purine Antimetabolite [EPC] 1 0.0000
7 Proteasome Inhibitor [EPC] 1 0.0000
8 Janus Kinase Inhibitor [EPC] 1 0.0000
9 Thalidomide Analog [EPC] 3 0.0000
See all drug classes enriched for association with RUNX1 GENE MUTATION